Pharmaceutical formulations containing acrivastine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4954350
SERIAL NO

07355142

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a controlled release pharmaceutical formulation for oral administration which comprises discrete units comprising acrivastine or a salt thereof coated with a mixture containing: (a) a copolymer or polymer containing repeating monomer units selected from alkyl esters of acrylic and methacrylic acids and (b) ethyl cellulose, and a process for preparing such formulations.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BURROUGHS WELLCOME CO.;MEDEVA CALIFORNIA, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gamlen, Michael J D Dartford, GB2 4 70
Jones, Harry P Dartford, GB2 5 109
Mackey, Robert J Dartford, GB2 4 83

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation